-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BN/5TGL8fjdvu+hmIejHe5YBctVh0Mb/Vp7se56DkqZhj/HMiGFaqacj0bBfzu8t YPj3oxEIaSnh8rwJ6zfpfg== 0001209191-06-010322.txt : 20060214 0001209191-06-010322.hdr.sgml : 20060214 20060214152824 ACCESSION NUMBER: 0001209191-06-010322 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051231 FILED AS OF DATE: 20060214 DATE AS OF CHANGE: 20060214 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOLAND JAMES C CENTRAL INDEX KEY: 0001203531 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 06614084 BUSINESS ADDRESS: BUSINESS PHONE: 216-420-2800 MAIL ADDRESS: STREET 1: CAVS/GUND ARENA COMPANY STREET 2: ONE CENTER COURT CITY: CLEVELAND STATE: OH ZIP: 44115 5 1 doc5.xml FORM 5 SUBMISSION X0202 5 2005-12-31 0 0 0 0000742112 INVACARE CORP IVC 0001203531 BOLAND JAMES C ONE INVACARE WAY ELYRIA OH 44035 1 0 0 0 Common Shares 1007.5822 D Stock Option (Right to Buy) Common Shares 53541 53541 D No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5. The reporting person holds previously reported options to buy 53,541 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 1992 Non-Employee Directors Stock Option Plan, the Invacare Corporation 1994 Performance Plan and the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between October 30, 1998 and December 16, 2005, at exercise prices between $16.03 and $47.01 per share, will expire between October 30, 2008 and December 16, 2015 and became or will become exercisable between October 30, 1999 and January 1, 2011. /s/ James C. Boland by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney dated August 24, 2004 on file with the Commission. 2006-02-14 -----END PRIVACY-ENHANCED MESSAGE-----